These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38014592)

  • 1. Preclinical Efficacy And Safety Evaluation of AAV-OTOF in DFNB9 Mouse Model And Nonhuman Primate.
    Qi J; Zhang L; Tan F; Zhang Y; Zhou Y; Zhang Z; Wang H; Yu C; Jiang L; Liu J; Chen T; Wu L; Zhang S; Sun S; Sun S; Lu L; Wang Q; Chai R
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306201. PubMed ID: 38014592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness.
    Qi J; Tan F; Zhang L; Lu L; Zhang S; Zhai Y; Lu Y; Qian X; Dong W; Zhou Y; Zhang Z; Yang X; Jiang L; Yu C; Liu J; Chen T; Wu L; Tan C; Sun S; Song H; Shu Y; Xu L; Gao X; Li H; Chai R
    Adv Sci (Weinh); 2024 Mar; 11(11):e2306788. PubMed ID: 38189623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.
    Zhang L; Wang H; Xun M; Tang H; Wang J; Lv J; Zhu B; Chen Y; Wang D; Hu S; Gao Z; Liu J; Chen ZY; Chen B; Li H; Shu Y
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101154. PubMed ID: 38027066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin.
    Tang H; Wang H; Wang S; Hu SW; Lv J; Xun M; Gao K; Wang F; Chen Y; Wang D; Wang W; Li H; Shu Y
    Hum Genet; 2023 Feb; 142(2):289-304. PubMed ID: 36383253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Many Faces of DFNB9: Relating
    Vona B; Rad A; Reisinger E
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33256196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel splice site variant of OTOF in the Korean nonsyndromic hearing loss population with low prevalence of the OTOF mutations.
    Jin YJ; Park J; Kim AR; Rah YC; Choi BY
    Int J Pediatr Otorhinolaryngol; 2014 Jul; 78(7):1030-5. PubMed ID: 24814232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.
    Iwasa YI; Nishio SY; Sugaya A; Kataoka Y; Kanda Y; Taniguchi M; Nagai K; Naito Y; Ikezono T; Horie R; Sakurai Y; Matsuoka R; Takeda H; Abe S; Kihara C; Ishino T; Morita SY; Iwasaki S; Takahashi M; Ito T; Arai Y; Usami SI
    PLoS One; 2019; 14(5):e0215932. PubMed ID: 31095577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model.
    Wang H; Xun M; Tang H; Zhao J; Hu S; Zhang L; Lv J; Wang D; Chen Y; Liu J; Li GL; Wang W; Shu Y; Li H
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102135. PubMed ID: 38404504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery kinetics of dual AAV-mediated human otoferlin expression.
    Sellon JB; So KS; D'Arcangelo A; Cancelarich S; Drummond MC; Slade PG; Pan N; Gibson TM; Yang T; Burns JC; Palermo AT; Becker L
    Front Mol Neurosci; 2024; 17():1376128. PubMed ID: 38952419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
    Iwasa YI; Nishio SY; Yoshimura H; Sugaya A; Kataoka Y; Maeda Y; Kanda Y; Nagai K; Naito Y; Yamazaki H; Ikezono T; Matsuda H; Nakai M; Tona R; Sakurai Y; Motegi R; Takeda H; Kobayashi M; Kihara C; Ishino T; Morita SY; Iwasaki S; Takahashi M; Furutate S; Oka SI; Kubota T; Arai Y; Kobayashi Y; Kikuchi D; Shintani T; Ogasawara N; Honkura Y; Izumi S; Hyogo M; Ninoyu Y; Suematsu M; Nakayama J; Tsuchihashi N; Okami M; Sakata H; Yoshihashi H; Kobayashi T; Kumakawa K; Yoshida T; Esaki T; Usami SI
    Hum Genet; 2022 Apr; 141(3-4):865-875. PubMed ID: 34536124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA base editing therapy cures hearing loss induced by OTOF gene mutation.
    Xue Y; Tao Y; Wang X; Wang X; Shu Y; Liu Y; Kang W; Chen S; Cheng Z; Yan B; Xie Y; Bi L; Jia H; Li J; Xiao Q; Chen L; Yao X; Shi L; Yang H; Wu H
    Mol Ther; 2023 Dec; 31(12):3520-3530. PubMed ID: 37915172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel OTOF gene mutations identified using a massively parallel DNA sequencing technique in DFNB9 deafness.
    Wang Y; Lu Y; Cheng J; Zhang L; Han D; Yuan H
    Acta Otolaryngol; 2018 Oct; 138(10):865-870. PubMed ID: 30073893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature-sensitive auditory neuropathy associated with an otoferlin mutation: Deafening fever!
    Marlin S; Feldmann D; Nguyen Y; Rouillon I; Loundon N; Jonard L; Bonnet C; Couderc R; Garabedian EN; Petit C; Denoyelle F
    Biochem Biophys Res Commun; 2010 Apr; 394(3):737-42. PubMed ID: 20230791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-Sensitive Auditory Neuropathy: Report of a Novel Variant of OTOF Gene and Review of Current Literature.
    Forli F; Capobianco S; Berrettini S; Bruschini L; Romano S; Fogli A; Bertini V; Lazzerini F
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837553
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy.
    Rodríguez-Ballesteros M; Reynoso R; Olarte M; Villamar M; Morera C; Santarelli R; Arslan E; Medá C; Curet C; Völter C; Sainz-Quevedo M; Castorina P; Ambrosetti U; Berrettini S; Frei K; Tedín S; Smith J; Cruz Tapia M; Cavallé L; Gelvez N; Primignani P; Gómez-Rosas E; Martín M; Moreno-Pelayo MA; Tamayo M; Moreno-Barral J; Moreno F; del Castillo I
    Hum Mutat; 2008 Jun; 29(6):823-31. PubMed ID: 18381613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual-AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock-out mice.
    Al-Moyed H; Cepeda AP; Jung S; Moser T; Kügler S; Reisinger E
    EMBO Mol Med; 2019 Jan; 11(1):. PubMed ID: 30509897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overloaded Adeno-Associated Virus as a Novel Gene Therapeutic Tool for Otoferlin-Related Deafness.
    Rankovic V; Vogl C; Dörje NM; Bahader I; Duque-Afonso CJ; Thirumalai A; Weber T; Kusch K; Strenzke N; Moser T
    Front Mol Neurosci; 2020; 13():600051. PubMed ID: 33488357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of cochlear implantation in two children with mutations in the OTOF gene.
    Rouillon I; Marcolla A; Roux I; Marlin S; Feldmann D; Couderc R; Jonard L; Petit C; Denoyelle F; Garabédian EN; Loundon N
    Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):689-96. PubMed ID: 16226319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model.
    Akil O; Dyka F; Calvet C; Emptoz A; Lahlou G; Nouaille S; Boutet de Monvel J; Hardelin JP; Hauswirth WW; Avan P; Petit C; Safieddine S; Lustig LR
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4496-4501. PubMed ID: 30782832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audibility, speech perception and processing of temporal cues in ribbon synaptic disorders due to OTOF mutations.
    Santarelli R; del Castillo I; Cama E; Scimemi P; Starr A
    Hear Res; 2015 Dec; 330(Pt B):200-12. PubMed ID: 26188103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.